Product Information

MEROPENEM IV 1 GM VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $5.0794 per EA under NDC 63323050830. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Oct 26, 2011. Its Orange Book therapeutic-equivalence code is AP.

MEROPENEM IV 1 GM VIAL

Meropenem
$5.0794per EA

Strength

1 g/20mL

NDC

63323050830

Classification

Generic

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route

INTRAVENOUS

Effective Date

11/18/2026

Active Ingredients

MEROPENEM

Approval Type

Generic (ANDA)

FDA Application

ANDA091404

FDA Approved

10/26/2011

TE Code

AP

On Market Since

10/26/2011

Pharmacological Classes

Price Statistics

The NADAC for MEROPENEM IV 1 GM VIAL has been published 136 times since Apr 17, 2024, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.

Current price$5.0794 per EA
All-time high$7.6153 (Nov 13, 2024)
All-time low$4.6687 (Aug 19, 2026)
52-week high$5.8381
52-week low$4.6687
Median price$5.6852
Average price$5.7479
Largest weekly change+15.4% (Oct 23, 2024)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

+0.7%

1M

+8.4%

3M

+8.8%

6M

-6.6%

1Y

-10.2%

3Y

N/A

5Y

N/A

All

-12.8%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEROPENEM IV 1 GM VIAL?

The current National Average Drug Acquisition Cost (NADAC) for MEROPENEM IV 1 GM VIAL, manufactured by Fresenius Kabi USA, LLC, is $5.0794 per EA (NDC 63323050830), effective Nov 18, 2026.

How has the price of MEROPENEM IV 1 GM VIAL changed over time?

Over the history we have for it, the NADAC for MEROPENEM IV 1 GM VIAL has declined 12.8%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for MEROPENEM IV 1 GM VIAL?

Since Apr 17, 2024, the NADAC for MEROPENEM IV 1 GM VIAL has ranged from a low of $4.6687 (Aug 19, 2026) to a high of $7.6153 (Nov 13, 2024), with a median of $5.6852 per EA.

Are there cheaper alternatives to MEROPENEM IV 1 GM VIAL?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEROPENEM IV 1 GM VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures MEROPENEM IV 1 GM VIAL?

MEROPENEM IV 1 GM VIAL (NDC 63323050830) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.